Juergen Roes

Title: Juergen Roes: Innovator in Monoclonal Antibody Development

Introduction

Juergen Roes is a prominent inventor based in Cologne, Germany. He is known for his significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has the potential to impact various medical applications.

Latest Patents

Juergen Roes holds a patent titled "Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof." This invention provides novel methods of obtaining autologous monoclonal antibodies (AMABs) to self-antigens or homologs thereof. The method involves obtaining a genetically engineered host animal that does not biosynthesize at least one epitope of the antigen. It utilizes the lack of self-tolerance of the host to the epitope to produce antibodies specific to the antigen. The invention also encompasses the AMABs produced by the methods and methods of isolating cells comprising the use of such AMABs that have specificity for a cell surface antigen. Juergen Roes has 1 patent to his name.

Career Highlights

Juergen Roes is associated with Miltenyi Biotec GmbH, a company that specializes in innovative solutions for cell and gene therapy. His work at Miltenyi Biotec has allowed him to further his research and development in the field of monoclonal antibodies.

Collaborations

Throughout his career, Juergen Roes has collaborated with notable scientists, including Klaus Rajewsky and Werner Mueller. These collaborations have contributed to the advancement of research in antibody development and related fields.

Conclusion

Juergen Roes is a key figure in the biotechnology sector, with a focus on monoclonal antibody innovation. His contributions through patents and collaborations continue to shape the future of medical research and applications.